Arcturus Therapeutics
ARCT
28 hedge funds and large institutions have $56.1M invested in Arcturus Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 10 closing their positions.
1,562% more capital inflows, than outflows
Capital inflows: $53.1M | Capital outflows: $3.2M
0% more funds holding
Funds holding: 28 → 28 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
46% less call options, than puts
Call options by funds: $552K | Put options by funds: $1.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$9.78M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$9.43M |
| 3 |
VM
VHCP Management
New York
|
+$9.43M |
| 4 |
Deerfield Management
New York
|
+$8.88M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$863K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$551K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$385K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$348K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$241K |
ARCT Hedge Fund Activity: Q1 2015 in Review
28 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q1 2015, worth a combined $56.1M — up 577% from $8.29M a quarter earlier.
Fund positioning in ARCT was balanced in Q1 2015: 10 funds opened new positions, 10 closed out, 7 added to existing stakes and 7 trimmed.
The largest buyer was Broadfin Capital, opening a new position worth an estimated $9.78M. The largest seller was Millennium Management, exiting entirely with an estimated $863K sold.
- 28 institutional investors held Arcturus Therapeutics (ARCT) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $56.1M of Arcturus Therapeutics stock for Q1 2015, up 577% quarter-over-quarter.
- 10 funds opened new Arcturus Therapeutics positions in Q1 2015 and 10 closed out, a net change of 0 holders.
- The largest Arcturus Therapeutics buyer in Q1 2015 was Broadfin Capital, an estimated $9.78M added.
- The largest Arcturus Therapeutics seller in Q1 2015 was Millennium Management, an estimated $863K sold.
Based on aggregated 13F filings for Q1 2015.